Comparing plasmapheresis and immunoglobulin-first therapy for patients with Stevens-Johnson syndrome and toxic epidermal necrolysis who previously received ineffective systemic corticosteroid therapy
1. No significant difference in mortality rates between inpatients with Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) who received ...
